Statins, Neuromuscular Degenerative Disease and an Amyotrophic Lateral Sclerosis-Like Syndrome
- 1 January 2007
- journal article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 30 (6), 515-525
- https://doi.org/10.2165/00002018-200730060-00005
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose SimvastatinCancer Cell, 2007
- Myopathy Associated with Atorvastatin‐Ezetimibe Combination TherapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Risks Associated With Statin TherapyCell Metabolism, 2006
- Presymptomatic Neuromuscular Disorders Disclosed Following Statin TreatmentArchives of Internal Medicine, 2006
- Final Conclusions and Recommendations of the National Lipid Association Statin Safety Assessment Task ForceThe American Journal of Cardiology, 2006
- The cerivastatin withdrawal crisis: a “post-mortem” analysisHealth Policy, 2004
- HMG‐CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesisJournal of Neurochemistry, 2004
- Geranylgeranyl-Pyrophosphate, an Isoprenoid of Mevalonate Cascade, Is a Critical Compound for Rat Primary Cultured Cortical Neurons to Protect the Cell Death Induced by 3-Hydroxy-3-Methylglutaryl-CoA Reductase InhibitionJournal of Neuroscience, 2000
- A Bayesian neural network method for adverse drug reaction signal generationEuropean Journal of Clinical Pharmacology, 1998
- MENINGOCOCCAL VACCINE - DO SOME CHILDREN EXPERIENCE SIDE-EFFECTS1989